Cargando…

Antifungal Susceptibilities of Cryptococcus neoformans

Susceptibility profiles of medically important fungi in less-developed countries remain uncharacterized. We measured the MICs of amphotericin B, 5-flucytosine, fluconazole, itraconazole, and ketoconazole for Cryptococcus neoformans clinical isolates from Thailand, Malawi, and the United States and f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Archibald, Lennox K., Tuohy, Marion J., Wilson, Deborah A., Nwanyanwu, Okey, Kazembe, Peter N., Tansuphasawadikul, Somsit, Eampokalap, Boonchuay, Chaovavanich, Achara, Reller, L.Barth, Jarvis, William R., Hall, Gerri S., Procop, Gary W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2004
Materias:	Dispatch
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322769/ https://www.ncbi.nlm.nih.gov/pubmed/15078612 http://dx.doi.org/10.3201/eid1001.020779

Ejemplares similares

AIDS Patient Death Caused by Novel Cryptococcus neoformans × C. gattii Hybrid
por: Bovers, Marjan, et al.
Publicado: (2008)

Interactions between antifungals and everolimus against Cryptococcus neoformans
por: Liang, Pin, et al.
Publicado: (2023)

Novel Antifungal Activity for the Lectin Scytovirin: Inhibition of Cryptococcus neoformans and Cryptococcus gattii
por: Jones, Tyler H., et al.
Publicado: (2017)

Antifungal activity of liriodenine on clinical strains of Cryptococcus neoformans and Cryptococcus gattii species complexes
por: Levorato-Vinche, Adriele Dandara, et al.
Publicado: (2022)

Antifungal potential of punicalagin against Cryptococcus neoformans species complex
por: Silva, Thaísa Cristina, et al.
Publicado: (2018)

Structure and inhibition of Cryptococcus neoformans sterylglucosidase to develop antifungal agents
por: Pereira de Sa, Nivea, et al.
Publicado: (2021)

The Environmental Effects on Virulence Factors and the Antifungal Susceptibility of Cryptococcus neoformans
por: Momin, Mahek, et al.
Publicado: (2021)

Investigation of Antifungal Mechanisms of Thymol in the Human Fungal Pathogen, Cryptococcus neoformans
por: Jung, Kwang-Woo, et al.
Publicado: (2021)

Antifungal activity of dendritic cell lysosomal proteins against Cryptococcus neoformans
por: Nelson, Benjamin N., et al.
Publicado: (2021)

Antifungal and Anti-Biofilm Activity of Essential Oil Active Components against Cryptococcus neoformans and Cryptococcus laurentii
por: Kumari, Poonam, et al.
Publicado: (2017)

etymologia: Cryptococcus neoformans
Publicado: (2008)

The capsule of Cryptococcus neoformans
por: Casadevall, Arturo, et al.
Publicado: (2018)

Essential Gene Discovery in the Basidiomycete Cryptococcus neoformans for Antifungal Drug Target Prioritization
por: Ianiri, Giuseppe, et al.
Publicado: (2015)

Galectin-3 impacts Cryptococcus neoformans infection through direct antifungal effects
por: Almeida, Fausto, et al.
Publicado: (2017)

851. Metabolic Changes Contributing to Age-Associated Antifungal Tolerance in Cryptococcus neoformans
por: Yoo, Kyungyoon, et al.
Publicado: (2023)

In vitro Antifungal Susceptibility Profiles of Cryptococcus neoformans var. grubii and Cryptococcus gattii Clinical Isolates in Guangxi, Southern China
por: Al-Odaini, Najwa, et al.
Publicado: (2021)

The Anti-helminthic Compound Mebendazole Has Multiple Antifungal Effects against Cryptococcus neoformans
por: Joffe, Luna S., et al.
Publicado: (2017)

First Isolation, Antifungal Susceptibility, and Molecular Characterization of Cryptococcus neoformans from the Environment in Croatia
por: Pllana-Hajdari, Donjeta, et al.
Publicado: (2019)

Cell Wall Integrity Pathway Involved in Morphogenesis, Virulence and Antifungal Susceptibility in Cryptococcus neoformans
por: de Oliveira, Haroldo Cesar, et al.
Publicado: (2021)

Allicin shows antifungal efficacy against Cryptococcus neoformans by blocking the fungal cell membrane
por: Li, Zhun, et al.
Publicado: (2022)

Methods for Antifungal Susceptibility Testing of the Cryptococcus neoformans/C. gattii Complex: Strengths and Limitations
por: Espinel-Ingroff, Ana, et al.
Publicado: (2023)

Synergistic antifungal interaction of N-(butylcarbamothioyl) benzamide and amphotericin B against Cryptococcus neoformans
por: Andriani, Gabriella Maria, et al.
Publicado: (2023)

Environmental Status of Cryptococcus neoformans and Cryptococcus gattii in Colombia
por: Serna-Espinosa, Briggith-Nathalia, et al.
Publicado: (2021)

Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India
por: Gutch, Ruchi Sethi, et al.
Publicado: (2015)

Cryptococcus gattii Genotype VGIIa Infection in Man, Japan, 2007
por: Okamoto, Koh, et al.
Publicado: (2010)

Whole-Genome Analysis of Cryptococcus gattii, Southeastern United States
por: Lockhart, Shawn R., et al.
Publicado: (2016)

Cryptococcus Species Other Than Cryptococcus neoformans and Cryptococcus gattii: Are They Clinically Significant?
por: Cano, Edison J, et al.
Publicado: (2020)

Surface Localization of Glucosylceramide during Cryptococcus neoformans Infection Allows Targeting as a Potential Antifungal
por: Rhome, Ryan, et al.
Publicado: (2011)

Screening and Antifungal Activity of a β-Carboline Derivative against Cryptococcus neoformans and C. gattii
por: Cruz, Kátia Santana, et al.
Publicado: (2019)

Host Carbon Dioxide Concentration Is an Independent Stress for Cryptococcus neoformans That Affects Virulence and Antifungal Susceptibility
por: Krysan, Damian J., et al.
Publicado: (2019)

Antifungal activity of eugenol on Cryptococcus neoformans biological activity and Cxt1p gene expression
por: Hassanpour, Parviz, et al.
Publicado: (2020)

Antifungal and Antibiofilm Efficacy of Paeonol Treatment Against Biofilms Comprising Candida albicans and/or Cryptococcus neoformans
por: Qian, Weidong, et al.
Publicado: (2022)

An Atypical ABC Transporter Is Involved in Antifungal Resistance and Host Interactions in the Pathogenic Fungus Cryptococcus neoformans
por: Winski, Christopher J., et al.
Publicado: (2022)

Giving a Hand: Synthetic Peptides Boost the Antifungal Activity of Itraconazole against Cryptococcus neoformans
por: Aguiar, Tawanny K. B., et al.
Publicado: (2023)

Cryptococcus neoformans Mar1 function links mitochondrial metabolism, oxidative stress, and antifungal tolerance
por: Telzrow, Calla L., et al.
Publicado: (2023)

Antifungal Peptide SP1 Damages Polysaccharide Capsule of Cryptococcus neoformans and Enhances Phagocytosis of Macrophages
por: Liu, Yan, et al.
Publicado: (2023)

Tourism and Specific Risk Areas for Cryptococcus gattii, Vancouver Island, Canada
por: Chambers, Catharine, et al.
Publicado: (2008)

Timing the Origin of Cryptococcus gattii sensu stricto, Southeastern United States
por: Lockhart, Shawn R., et al.
Publicado: (2018)

Mathematical modeling of pathogenicity of Cryptococcus neoformans
por: Garcia, Jacqueline, et al.
Publicado: (2008)

Cryptococcus neoformans: Tripping on Acid in the Phagolysosome
por: DeLeon-Rodriguez, Carlos M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v9mpca5rnk73nmvgbqq5dgrur8